Additionally, administration of MB109, a recombinant derivative of human BMP9, in obese mice enhances FGF21 expression, alleviates HFD-induced obesity, and reduces liver lipid droplets (Kim et al., 2016). Here, FGF21 is linked to obesity disorder.